Can the bowel substitute for the kidney in advanced renal failure?

Current Medical Research and Opinion

Volumn 25, Issue 8, 2009, Pages 1913-1918

  Friedman, Eli A ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Bacteria; Bowel; Kidney; Uremia

Indexed keywords

BACTERIAL ENZYME; INFUSION FLUID; PENICILLIN G; SMALLPOX VACCINE;

COST EFFECTIVENESS ANALYSIS; DIARRHEA; HEALTH CARE SYSTEM; HUMAN; INTESTINE FLORA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MEDICAL PRACTICE; MEDICAL SOCIETY; RENAL REPLACEMENT THERAPY; REVIEW; SMALLPOX;

DIALYSIS; DIARRHEA; HUMANS; INTESTINES; KIDNEY FAILURE, CHRONIC; PROBIOTICS; SORPTION DETOXIFICATION; UREMIA;

EID: 67650828069     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903069173     Document Type: Review

References (49)

1. Kolff WJ. A visiting scientist looks at the Arab refugee problem. Salt Lake City, Utah: Division of Artificial Organs, University of Utah, 1979: p.1
2. Life Magazine, Fall 1990, The most important Americans of the 20th Century
3. Kolff WJ. To live without heart and kidneys. Proc Eur Dial Transplant Assoc 1968;1:21-24
4. Friedman EA. Feasibility of a bionic kidney. Proc Int Conf Cybernetics Soc 1976;189-194
5. Smallpox: 30th Anniversary of Global Eradication, United States Public Health Service, Center for Disease Control. Available at: www.cdc.gov/Features/ SmallpoxEradication. [Last accessed June 5, 2009]
6. Jacobs C, Broyer M, Brunner FP, et al. Combined report on regular dialysis and transplantation in Europe, XI 1980. Proc European Dialysis Transplant Assoc 1980;18:4-58
7. Berlyne GM. Over 50 and uremic equals death. The failure of the British National Health Service to provide adequate dialysis facilities. Nephron. 1982;31(3):189-90
8. Friedman EA, Delano BG. Can the world afford trauma therapy? In Proceedings of the 8th International Congress on Nephrology. Athens Greece: S. Karger, 1981: pp. 677-83
9. Friedman EA. Facing the reality: the world cannot afford uremia therapy at the start of the 21st century. Artif Organs 1998;19:481-5
10. U.S. Renal Data System, USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Chapter 12, International Comparisons. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008
11. Friedman EA. Nephrology and the rationing of health care. Contrib Nephrol 1993;102:230-36
12. Poikolainen K, Eskola J. Health services resources and their relation to mortality from causes amenable to health care intervention: a cross-national study. Int J Epidemiol 1988;17:86-9
13. Friedman EA. Revelations behind a fallen curtain: dialysis restriction and the Berlin wall. Nephrol Dial Transplant 1994;9:242-3
14. Valek A, Wing AJ. Development of dialysis and transplant activity in the world during the seventies of the 20th century. Z Exp Chir Transplant Künstliche Organe 1984;17:86-9
15. Friedman EA. ESRD therapy: an American success story. JAMA 1996;275:1118-22
16. Friedman EA, Delano BG. Can the world afford uremia therapy? Proc 8th Internat Cong Nephrol. Athens: S. Karger, 1981:pp. 677-83
17. Chang TM. 50th anniversary of artificial cells: their role in biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy and nanorobotics. Artif Cells Blood Substit Immobil Biotechnol 2007;35(6):545-54
18. Chang TMS. Semipermeable microcapsules. Science 1964;146:524-7
19. Chang TM, MacIntosh FC, Mason SG. Semipermeable aqueous microcapsules. 1. Preparation and properties. Can J Physiol Pharmacol 1996;44:115-28
20. Safos S, Chang TM. Enzyme replacement therapy in ENU2 phenylketonuric mice using oral microencapsulated phenylalanine ammonia-lyase: a preliminary report. Artif Cells Blood Substit Immobil Biotechnol 1995;23:681-92
21. Liu ZC, Chang TM. Preliminary study on intrasplenic implantation of artificial cell bioencapsulated stem cells to increase the survival of 90% hepatectomized rats. Artif Cells Blood Substit Immobil Biotechnol 2009;8:1-5
22. Bruni S, Chang TM. Effect of donor strains and age of the recipient in the use of microencapsulated hepatocytes to control hyperbilirubinemia in the Gunn rat. Int J Artif Organs 1995;18:332-9
23. Friedman EA. Bowel as a kidney substitute in renal failure. Amer J Kidney Dis 1996;28:943-50
24. Thompson CJS. Terra Sigillata, a famous medicament of ancient times. Trans XVII Internat Med Congress 1914; London, Sect 23;433-40
25. Yatzidis H. Recherches sur l'épuration extra rénale à l'aide du charbon actif. Nephron 1964;1:310-12
26. Giordano C, Esposito R, Randazzo G, et al. Oxystarch as a gastrointestinal sorbent in uremia, in Kluthe R, Berlyne G, Burton B (eds) Uremia. Stuttgart: Georg Thieme Verlag, 1972: pp. 231-9
27. Yatzidis H, Koutsicos D, Digenis P. Newer oral sorbents in uremia. Clin Nephrol 1979;2:105-6
28. Niwa T, Yazawa T, Ise M, et al. Inhibitory effect of oral sorbent on accumulation of albumin-bound inoxyl sulfate in serum of experimental uremic rats. Nephron 1991;57:84-8
29. Schloerb PR. Intestinal dialysis for kidney failure. Personal experience. ASAIO Trans 1990;36(1):4-7
30. Kolff WJ. New ways of treating uremia. London: J. A. Churchill, 1947
31. van Noordwijk J. Early History in Kampen Dialysis & Transplantation 1982;11:15-18
32. Sparks RE, Mason NS, Meier PM, et al. Binders to remove uremic waste metabolites from the GI tract. Trans Am Soc Artif Intern Organs 1972;18:458-64
33. Sparks RE, MasonNS, Meier PM, et al. Removal of uremic waste metabolites from the intestinal tract by encapsulated carbon and oxidized starch. Trans AmSocArtif Intern Organs 1971;17:229-38
34. Giordano C, Esposito R, Demma G. The possibility of reducing the blood nitrogen level in humans by the administration of a polyaldehyde. Bull Soc Ital Biol Sper 1968;44:2232-4
35. Giordano C, Esposito R, Pluvio M. Oxycellulose and ammonia-treated oxystarch as insoluble polyaldehydes in uremia. Kidney Int Suppl 1975;Feb(3):380-2
36. Friedman EA, Fastook J, Beyer MM, et al. Potassium and nitrogen binding in the human gut by ingested oxidized starch. Trans Amer Soc Artif Internal Organs 1974;20:33-43
37. Okada K, Takahashi S. Correction by oral adsorbent of abnormal digestive tract milieu in rats with chronic renal failure. Nephrol Dial Transplant 1995;10:671-6
38. Miles AM, Fleishacker J, Hyppolite G, et al. Oral sorbent (AST-120) slows uremia progression in 7/8th nephrectomized rats (Abstract). J Amer Soc Nephrology 1995;6:1024
39. Savarino SJ. A legacy in 20th-century medicine: Robert Allan Phillips and the taming of cholera. Clin Infect Dis 2002;35(6):713-20
40. Young TK, Lee SC, Tang CK. Diarrhea therapy of uremia. Clin Nephrol 1979;11(2):86-91
41. Young TK, Lee SC, Tai LN. Mannitol absorption and excretion in uremic patients regularly treated with gastrointestinal perfusion. Nephron 1980;25:112-6
42. Korhonen M, Ahvenjarvi S, Vanhatalo A, et al. Supplementing barley or rapeseed meal to dairy cows fed grass-red clover silage: II. Amino acid profile of microbial fractions. J Anim Sci 2002;80:2188-96
43. Singh J, Singh AP, Peshin PK, et al. Studies on the effects of total nephrectomy in sheep. Can J Comp Med 1983;47:217-21
44. Biochemical changes following bilateral nephrectomy in the bovine. Watts C, Campbell JR. Res Vet Sci 1970;11:508-14
45. Virtanen AI. Milk production of cows on protein-free feed. Science 1966;53:1603-14
46. SetäläK. The promise of enzymes in therapy of uremia. I. Theoretical basis - bowel physiology. Nephron 1984;37:1-6
47. SetäläK. Bacterial enzymes in uremia management. Kidney Int Suppl 1978;8:S194-202
48. Prakash S, Chang TMS. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nature Med 1996;2:883-7
49. Ranganathan N, Friedman EA, Tam P, Rao V, Ranganathan P, Dheer R. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Curr Med Res Opin 2009;25:1919-30